Oral Capsule

MK-677 (25mg) x 60 Tablets

The Science

What is MK-677 (Ibutamoren)?

MK-677 (ibutamoren mesylate; also designated MK-0677) is a synthetic, non-peptide agonist of the ghrelin receptor (GHSR-1a) developed by Merck in the 1990s. By mimicking ghrelin—the endogenous 'hunger hormone'—MK-677 stimulates the pituitary gland and hypothalamus to secrete growth hormone (GH) in a pulsatile, physiological manner. The resulting GH pulses subsequently stimulate hepatic IGF-1 production.

Unlike exogenous recombinant GH, MK-677 does not suppress the body's endogenous GH axis and preserves the natural pulsatile secretion pattern. It has been studied in randomized controlled trials in healthy older adults, GH-deficient children, and research subjects with hip fracture.

It is distinct from anabolic steroids and does not directly engage androgen receptors; its anabolic effects are mediated through the GH/IGF-1 axis.

Laboratory Observations

Research-Observed Areas of Interest

Bone Mineral Density

Clinical research suggests MK-677 increases bone turnover markers and, in longer-term studies, bone mineral density—driven by IGF-1-mediated osteoblast activity. This has generated interest in research on age-related osteoporosis and fracture recovery.

IGF-1 Elevation in GH Deficiency

Studies in adults and children with GH deficiency have demonstrated that MK-677 can restore IGF-1 concentrations into the normal range, offering a potential oral alternative to GH injections in research contexts.

Sleep Quality

Consistent with GH's role in slow-wave sleep architecture, clinical research has reported that MK-677 increases the duration of Stage IV (deep) sleep and REM sleep—effects that may contribute to recovery and memory consolidation in research subjects.

Recovery from Hip Fracture

A study in elderly hip fracture research subjects found MK-677 significantly improved functional recovery and stair-climbing ability compared to placebo, suggesting potential utility in post-surgical rehabilitation research.

Mechanism of Action

How MK-677 Works

MK-677 drives GH secretion and downstream anabolic signaling through three interconnected actions:

1

Ghrelin Receptor (GHSR-1a) Agonism

MK-677 binds to the growth hormone secretagogue receptor type 1a (GHSR-1a), which is expressed on pituitary somatotroph cells and hypothalamic neurons. This binding mimics the GH-releasing action of ghrelin, triggering calcium influx and cAMP signaling that stimulates GH secretion in a pulsatile pattern closely resembling physiological release.

2

GH-IGF-1 Axis Activation

Elevated GH pulses triggered by MK-677 stimulate hepatic IGF-1 production. IGF-1 mediates downstream anabolic effects—promoting nitrogen retention, muscle protein synthesis, satellite cell activation, and bone matrix deposition. Research in older adults has documented sustained elevations in both GH and IGF-1 throughout multi-month studies.

3

GHRH Potentiation and Somatostatin Inhibition

Beyond direct receptor activation, MK-677 amplifies the GH response to growth hormone-releasing hormone (GHRH) and suppresses somatostatin-mediated inhibition of GH release. This dual mechanism results in greater GH pulse amplitude relative to GHRH administration alone.

FAQ

Frequently Asked Questions

Is MK-677 the same as growth hormone?+

No. MK-677 is a secretagogue—it stimulates the pituitary to produce and release the body's own GH rather than replacing it with exogenous hormone. This preserves the pulsatile, physiological GH release pattern and avoids the continuous supraphysiological exposure associated with recombinant GH injections.

Does MK-677 affect testosterone or estrogen levels?+

MK-677 does not directly interact with androgen or estrogen receptors. It is not a steroid and does not suppress endogenous testosterone production. Its anabolic effects are mediated exclusively through the GH/IGF-1 axis.

Research-Only Notice

MK-677 (25mg) x 60 Tablets is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.